Opicapone
Opicapone (pronounced oh-pi-KA-pone) is a medication used in the treatment of Parkinson's disease. It is classified as a COMT inhibitor, which stands for Catechol-O-methyltransferase inhibitor.
Pronunciation
The pronunciation of Opicapone is oh-pi-KA-pone.
Etymology
The etymology of Opicapone is not well documented. However, it is known that the name is derived from its chemical structure and its function as a COMT inhibitor.
Usage
Opicapone is used as an adjunct therapy in the treatment of Parkinson's disease. It is often used in combination with Levodopa and Carbidopa, two other medications commonly used to manage the symptoms of Parkinson's disease.
Mechanism of Action
Opicapone works by inhibiting the enzyme COMT, which is responsible for the breakdown of dopamine in the brain. By inhibiting this enzyme, Opicapone increases the availability of dopamine, thereby helping to alleviate the symptoms of Parkinson's disease.
Related Terms
- Parkinson's disease: A neurodegenerative disorder characterized by the death of dopamine-producing cells in the brain.
- Levodopa: A medication that is converted into dopamine in the brain.
- Carbidopa: A medication that is used in combination with levodopa to increase its effectiveness.
- COMT inhibitor: A class of drugs that inhibit the enzyme COMT, thereby increasing the availability of dopamine in the brain.
See Also
External links
- Medical encyclopedia article on Opicapone
- Wikipedia's article - Opicapone
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski